Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01133847 · ClinicalTrials.gov registry record · Phase 4
Interventions for Children With Attention and Reading Disorders
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 222
- Enrollment target
NCT01133847: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT01133847 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 222 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01133847, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 222 participants
- Enrollment target
Study Summary
The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) ADHD treatment alone, (b) RD treatment alone, or (c) the combination of ADHD and RD treatment.
Primary Outcome
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
Interventions
- DRUG Methylphenidate
- DRUG Atomoxetine
- BEHAVIORAL Parent Training
- BEHAVIORAL Intensive reading instruction
- DRUG Mixed Salt Amphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2010-11 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
What the finished NCT01133847 record still lists
NCT01133847 is an interventional study that assigns participants to a tested intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 5 interventions - of which Methylphenidate is the first listed.
NCT01133847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01133847 about?
NCT01133847 is a clinical study titled "Interventions for Children With Attention and Reading Disorders". The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcome...
What is the current status of trial NCT01133847?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 222 participants. The study started on 2010-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01133847?
The interventions under investigation include: Methylphenidate (DRUG), Atomoxetine (DRUG), Parent Training (BEHAVIORAL), Intensive reading instruction (BEHAVIORAL), Mixed Salt Amphetamine (DRUG).
Who is sponsoring clinical trial NCT01133847?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01133847's enrollment target sits among peer trials
222 383rd of 2000 higher than 1,618 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia